Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
Capital Southwest Corp (CSWC) Prices $62.5M Notes Offering
-
Capital Southwest Corporation Prices Public Offering of $62.5 million 7.75% Notes due 2028
-
Capital Southwest Corp (CSWC) Announces Notes Offering
-
Capital Southwest Corporation Announces Offering of Notes
-
Kiora Pharmaceuticals Announces Closing of $6.3 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
-
Check-Cap (CHEK) Announces Review of Strategic Alternatives and Reduction in Workforce
-
Check-Cap Announces Review of Strategic Alternatives and Reduction in Workforce
-
Engine Capital Issues Letter to the Board of Directors of Avantax Regarding the Urgent Need to Explore Strategic Alternatives (AVTA)
-
Engine Capital Issues Letter to the Board of Directors of Avantax Regarding the Urgent Need to Explore Strategic Alternatives
-
Advisor Group Accelerates Evolution of Ria Channel with Addition of Seasoned Industry Executive
-
Kiora Pharmaceuticals (KPRX) Prices $5M Share Offering at $1.10/sh
-
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
-
Advisor Group Closes First Ever NXT Conference and Announces Date to Unveil New Combined Brand
-
Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering
-
Biodexa Pharmaceuticals (BDRX) Announces 22.14M Share Offering at $0.15/sh
-
Biodexa Pharmaceuticals PLC Announces US$3.32 Million Registered Direct Offering
-
Pyxis Oncology (PYXS) to Acquire Apexigen (APGN) for $0.64/sh
-
Pyxis Oncology to Acquire Apexigen
-
Gladstone Investment (GAIN) Prices $65M Notes Offering
-
Gladstone Investment Corporation Prices Public Offering of 8.00% Notes due 2028
-
Gladstone Investment Corporation Announces Notes Offering
-
CohBar (CWBR) and Morphogenesis, Inc. Enter into Definitive Merger Agreement
-
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunoth
-
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunoth
-
Instant view: Morgan Stanley CEO Gorman plans to step down
-
Trailblazer Merger Corporation I Announces the Separate Trading of its Class A Common Stock and Rights Commencing May 15, 2023
-
Zynerba Pharmaceuticals Reports First Quarter 2023 Financial ResultsĀ and Operational Highlights
-
Form 13F-NT LADENBURG THALMANN ASSET For: Mar 31
-
Onconova Therapeutics to Participate in Ladenburg Thalmann Virtual R&D Showcase on Narazaciclib in Endometrial Cancer
-
Onconova Therapeutics to Participate in Ladenburg Thalmann Virtual R&D Showcase on Narazaciclib in Endometrial Cancer
-
Lightwave Logic, Inc. (LWLG) Provides Q1 Update
-
Lightwave Logic Provides First Quarter 2023 Corporate Update
-
Oxford Square Capital Corp. (OXSQ) Announces Transferable Rights Offering
-
Oxford Square Capital Corp. Announces Transferable Rights Offering
-
Advisor Group Welcomes Tom Delich and his Team to its Network
-
Saratoga Investment Corp. Announces Fiscal Year-End and Fourth Quarter 2023 Financial Results
-
Quotes: US regional banks fall as FRC failure shakes faith in banking sector recovery
-
PacWest, Western Alliance shares tumble as US regional bank fears persist
-
Holistiplan Tax Planning Technology Now Available to Advisor Group Advisors
-
Immutep Announces KOL Event Focused on Eftilagimod Alpha in Non-Small Cell Lung Cancer and Head & Neck Squamous Cell Carcinoma
-
Golden Star Acquisition Corporation (GODN) Prices 6M Unit IPO at $10/unit
-
Golden Star Acquisition Corporation Announces Pricing of $60 Million Initial Public Offering
-
NovaBay Pharma (NBY) Announces $3M Convertible Note Financing
-
NovaBay Pharmaceuticals Announces $3.0 Million Convertible Note Financing
-
Gryphon Digital Mining to Present at the Ladenburg Thalmann Tech Expo 2023
-
Advisor Group Announces Plan to Simplify Business Structure Under One New Brand
-
MySize to Present at Ladenburg Thalmann Tech Expo on April 27, 2023 in New York City
-
The Real Brokerage to Present at the Ladenburg Thalmann Tech Expo 2023
-
ARCA biopharma Announces First Quarter 2023 Financial Results
-
Windtree Therapeutics Announces Closing of $12.42 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

